RESUMEN
The eastern Mediterranean region is a vital hub for oil transportation and production because of its strategic location between Europe, Asia, and Africa. But its unique attributes, including narrow shipping routes, heavy marine traffic, and proximity to vulnerable ecosystems, render it particularly susceptible to accidental oil spills. In this research, an oil spill detection model, along with bathymetric and oceanographic parameters, was used to track oil spills that occurred at the Syrian Baniyas Station in the Eastern Mediterranean on August 23, 2021. Furthermore, the study employed a pairwise comparison matrix (PWCM) to assess the relative importance of wind speed and direction, water depth, and sea surface temperature (SST) in the dispersion of oil spills. Analysis of Sentinel-1 data obtained prior to, during, and after the incident revealed the accumulation of oil slicks along the Syrian coast from Baniyas to Latakia for up to twenty days. The spilled oil reached the coast of Cyprus six days after the incident. The study determined that wind speed and direction played a critical role in the dispersion of spilled oil, while water depth and SST were comparatively less significant factors in this process. The overall accuracy (OA) and Kappa coefficient (KC) for land, water, and oil slick classes derived from the random forest (RF) algorithm ranged from 90 % to 98 % and from 0.86 to 0.98, respectively. The spread of oil slicks at the incident location was revealed by the decorrelation stretch and band ratios of Sentinel-2 MultiSpectral Instrument (MSI) data. The accidental oil spill could have negative effects on the organic carbon cycle, chlorophyll production, and ecosystem productivity. It is essential to consider the vulnerability of specific regions in the Eastern Mediterranean to oil spills when developing adaptation strategies.
Asunto(s)
Contaminación por Petróleo , Contaminación por Petróleo/análisis , Ecosistema , Accidentes , Agua/análisis , Chipre , Monitoreo del AmbienteRESUMEN
As photoreceptor cells die during retinal degeneration, the surrounding microenvironment undergoes significant changes that are increasingly recognized to play a prominent role in determining the efficacy of therapeutic interventions. Chondroitin Sulphate Proteoglycans (CSPGs) are a major component of the extracellular matrix that have been shown to inhibit neuronal regrowth and regeneration in the brain and spinal cord, but comparatively little is known about their expression in retinal degeneration. Here we provide a comprehensive atlas of the expression patterns of four individual CSPGs in three models of inherited retinal degeneration and wildtype mice. In wildtype mice, Aggrecan presented a biphasic expression, while Neurocan and Phosphacan expression declined dramatically with time and Versican expression remained broadly constant. In degeneration, Aggrecan expression increased markedly in Aipl1-/- and Pde6brd1/rd1, while Versican showed regional increases in the periphery of Rho-/- mice. Conversely, Neurocan and Phosphacan broadly decrease with time in all models. Our data reveal significant heterogeneity in the expression of individual CSPGs. Moreover, there are striking differences in the expression patterns of specific CSPGs in the diseased retina, compared with those reported following injury elsewhere in the CNS. Better understanding of the distinct distributions of individual CSPGs will contribute to creating more permissive microenvironments for neuro-regeneration and repair.
Asunto(s)
Neurocano , Degeneración Retiniana , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Agrecanos/genética , Agrecanos/metabolismo , Animales , Proteoglicanos Tipo Condroitín Sulfato/genética , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Lectinas Tipo C/metabolismo , Ratones , Proteínas del Tejido Nervioso/metabolismo , Neurocano/metabolismo , Proteínas Tirosina Fosfatasas Clase 5 Similares a Receptores/metabolismo , Retina/metabolismo , Degeneración Retiniana/genética , Versicanos/genética , Versicanos/metabolismoRESUMEN
This study aims to monitor and map the oil spills which occurred from 2019 to 2021 along the northeastern portion of the Nile Delta using Sentinel-1 (SAR) and Sentinel-2 (MSI) data. The examination of VV polarized SAR-C images displayed the presence of the oil spills as dark spots of different sizes. These images were processed using the oil spills detection model in SNAP Toolbox. The oceanographic parameters that may influence the dispersal of oil spills were mapped using GIS technique. This study identified 29 oil spills during the study period in the research area. The largest spill was detected on February 23, 2019, and covered an area of about 10.5 km2. The band ratios and decorrelation stretch methods of available Sentinel-2 data confirmed the results of SAR-C data. The accuracy assessment of spills was achieved using Parallelepiped supervised classification model. The results demonstrated that the overall accuracy (OA) and Kappa coefficient (KC) for seawater, land, and oil spills classes were between 86% and 98% and 0.73% and 0.97%, respectively. The sensitivity zone of oil spills was higher in winter than in summer. This study proved the efficiency of VV polarized data of Sentinel-1 sensor for detection and mapping of oil spills. Several management strategies are needed in the offshore zone of the Nile Delta to limit oil pollution effects on the marine environment.
Asunto(s)
Contaminación por Petróleo , Monitoreo del Ambiente/métodos , Oceanografía , Contaminación por Petróleo/análisis , Agua de MarRESUMEN
Macular degeneration is a leading cause of blindness. Treatments to rescue vision are currently limited. Here, we study how loss of central vision affects lateral feedback to spared areas of the human retina. We identify a cone-driven gain control mechanism that reduces visual function beyond the atrophic area in macular degeneration. This finding provides an insight into the negative effects of geographic atrophy on vision. Therefore, we develop a strategy to restore this feedback mechanism, through activation of laterally projecting cells. This results in improved vision in Cnga3-/- mice, which lack cone function, as well as a mouse model of geographic atrophy. Our work shows that a loss of lateral gain control contributes to the vision deficit in macular degeneration. Furthermore, in mouse models we show that lateral feedback can be harnessed to improve vision following retinal degeneration.
Asunto(s)
Atrofia Geográfica , Degeneración Macular , Degeneración Retiniana , Animales , Atrofia Geográfica/genética , Atrofia Geográfica/terapia , Degeneración Macular/genética , Ratones , Células Fotorreceptoras Retinianas Conos/fisiología , Degeneración Retiniana/complicaciones , Degeneración Retiniana/genética , Degeneración Retiniana/terapia , Visión OcularRESUMEN
Soil salinization is one of the major environmental problems facing agricultural lands in arid and semiarid areas of the world because of its detrimental impacts on agricultural production and on the sustainable development of land resources. Hence, predicting soil salinity is essential to avoiding further soil degradation. The present study is intended to develop a model for predicting soil salinity in soils around Idku Lake by using remote sensing and geographic information system techniques. This lake is a shallow brackish basin located in the western part of the Nile Delta. For this purpose, Landsat 8-OLI images and shuttle radar topography mission 1Arc-Second Digital Elevation Model data were utilized in this research. A total of 91 surface samples were collected across the study area at a depth between 0 and 30 cm and were analyzed via traditional laboratory analysis methods. Five environmental parameters were used in the design of the soil salinity model. A pairwise comparison matrix was used to calculate the factor weight value for each of the layers. A linear regression model was used to plot the relationship between the EC value and raster value of the salinity map derived from the overlay model. According to the results obtained from a pairwise comparison of the factor layers, water table level was the greatest influential factor of soil salinity, followed by landforms. The validation of the model demonstrated a high degree of correlation (R2 = 0.72) between the measured EC values and the salinity values derived from the model. Furthermore, this model could be a useful tool for predicting soil salinity with a suitable validation.
Asunto(s)
Monitoreo del Ambiente/métodos , Sistemas de Información Geográfica , Tecnología de Sensores Remotos , Salinidad , Suelo/química , Agricultura , Egipto , Lagos/química , RiesgoRESUMEN
The authors originally published this article under the incorrect license type; this has now been corrected and is published under the CC-BY license.
RESUMEN
The retinal pigment epithelium (RPE) interacts closely with photoreceptors to maintain visual function. In degenerative diseases such as Stargardt disease and age-related macular degeneration, the leading cause of blindness in the developed world, RPE cell loss is followed by photoreceptor cell death. RPE cells can proliferate under certain conditions, suggesting an intrinsic regenerative potential, but so far this has not been utilised therapeutically. Here, we used E2F2 to induce RPE cell replication and thereby regeneration. In both young and old (2 and 18 month) wildtype mice, subretinal injection of non-integrating lentiviral vector expressing E2F2 resulted in 47% of examined RPE cells becoming BrdU positive. E2F2 induced an increase in RPE cell density of 17% compared with control vector-treated and 14% compared with untreated eyes. We also tested this approach in an inducible transgenic mouse model of RPE loss, generated through activation of diphtheria toxin-A gene. E2F2 expression resulted in a 10-fold increase in BrdU uptake and a 34% increase in central RPE cell density. Although in mice this localised rescue is insufficiently large to be demonstrable by electroretinography, a measure of massed retinal function, these results provide proof-of-concept for a strategy to induce in situ regeneration of RPE for the treatment of RPE degeneration.
Asunto(s)
Factor de Transcripción E2F2/genética , Técnicas de Transferencia de Gen , Terapia Genética , Degeneración Macular/terapia , Epitelio Pigmentado de la Retina/fisiopatología , Envejecimiento/genética , Envejecimiento/metabolismo , Animales , Proliferación Celular/genética , Toxina Diftérica/genética , Modelos Animales de Enfermedad , Vectores Genéticos , Ratones , Ratones Transgénicos , Fragmentos de Péptidos/genética , Regeneración , Epitelio Pigmentado de la Retina/citología , Epitelio Pigmentado de la Retina/metabolismoRESUMEN
Photoreceptor replacement by transplantation is proposed as a treatment for blindness. Transplantation of healthy photoreceptor precursor cells into diseased murine eyes leads to the presence of functional photoreceptors within host retinae that express an array of donor-specific proteins. The resulting improvement in visual function was understood to be due to donor cells integrating within host retinae. Here, however, we show that while integration occurs the majority of donor-reporter-labelled cells in the host arises as a result of material transfer between donor and host photoreceptors. Material transfer does not involve permanent donor-host nuclear or cell-cell fusion, or the uptake of free protein or nucleic acid from the extracellular environment. Instead, RNA and/or protein are exchanged between donor and host cells in vivo. These data require a re-evaluation of the mechanisms underlying rescue by photoreceptor transplantation and raise the possibility of material transfer as a strategy for the treatment of retinal disorders.
Asunto(s)
Células Fotorreceptoras de Vertebrados/trasplante , Retina/trasplante , Enfermedades de la Retina/terapia , Animales , Femenino , Proteínas Fluorescentes Verdes/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Microscopía Confocal , Células 3T3 NIH , ARN/metabolismo , Degeneración Retiniana/metabolismo , Células Fotorreceptoras Retinianas Bastones/metabolismo , Trasplante de Células Madre , Donantes de TejidosRESUMEN
Leber congenital amaurosis is a group of inherited retinal dystrophies that cause severe sight impairment in childhood; RPE65-deficiency causes impaired rod photoreceptor function from birth and progressive impairment of cone photoreceptor function associated with retinal degeneration. In animal models of RPE65 deficiency, subretinal injection of recombinant adeno-associated virus (AAV) 2/2 vectors carrying RPE65 cDNA improves rod photoreceptor function, and intervention at an early stage of disease provides sustained benefit by protecting cone photoreceptors against retinal degeneration. In affected humans, administration of these vectors has resulted to date in relatively modest improvements in photoreceptor function, even when retinal degeneration is comparatively mild, and the duration of benefit is limited by progressive retinal degeneration. We conclude that the demand for RPE65 in humans is not fully met by current vectors, and predict that a more powerful vector will provide more durable benefit. With this aim we have modified the original AAV2/2 vector to generate AAV2/5-OPTIRPE65. The new configuration consists of an AAV vector serotype 5 carrying an optimized hRPE65 promoter and a codon-optimized hRPE65 gene. In mice, AAV2/5-OPTIRPE65 is at least 300-fold more potent than our original AAV2/2 vector.
Asunto(s)
Dependovirus/genética , Terapia Genética/métodos , Vectores Genéticos/genética , Amaurosis Congénita de Leber/terapia , cis-trans-Isomerasas/genética , Células 3T3 , Animales , Femenino , Vectores Genéticos/administración & dosificación , Células HEK293 , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Conejos , cis-trans-Isomerasas/metabolismoRESUMEN
The X-linked RP3 gene codes for the ciliary protein RPGR and accounts for over 10% of inherited retinal degenerations. The critical RPGR-ORF15 splice variant contains a highly repetitive purine-rich linker region that renders it unstable and difficult to adapt for gene therapy. To test the hypothesis that the precise length of the linker region is not critical for function, we evaluated whether adeno-associated virus-mediated replacement gene therapy with a human ORF15 variant containing in-frame shortening of the linker region could reconstitute RPGR function in vivo. We delivered human RPGR-ORF15 replacement genes with deletion of most (314 codons, 'short form') or 1/3 (126 codons, 'long form') of the linker region to Rpgr null mice. Human RPGR-ORF15 expression was detected post treatment with both forms of ORF15 transgenes. However, only the long form correctly localized to the connecting cilia and led to significant functional and morphological rescue of rods and cones. Thus the highly repetitive region of RPGR is functionally important but that moderate shortening of its length, which confers the advantage of added stability, preserves its function. These findings provide a theoretical basis for optimizing replacement gene design in clinical trials for X-linked RP3.
Asunto(s)
Dependovirus/genética , Proteínas del Ojo/genética , Terapia Genética , Retinitis Pigmentosa/terapia , Empalme Alternativo , Animales , Modelos Animales de Enfermedad , Quinasa 1 del Receptor Acoplado a Proteína-G/genética , Humanos , Ratones , Ratones Endogámicos C57BL , Regiones Promotoras Genéticas , Células Fotorreceptoras Retinianas Conos/fisiología , Células Fotorreceptoras Retinianas Bastones/fisiología , Retinitis Pigmentosa/genéticaRESUMEN
Recent clinical trials of retinal pigment epithelium gene (RPE65) supplementation therapy in Leber congenital amaurosis type 2 patients have demonstrated improvements in rod and cone function, but it may be some years before the effects of therapy on photoreceptor survival become apparent. The Rpe65-deficient dog is a very useful pre-clinical model in which to test efficacy of therapies, because the dog has a retina with a high degree of similarity to that of humans. In this study, we evaluated the effect of RPE65 gene therapy on photoreceptor survival in order to predict the potential benefit and limitations of therapy in patients. We examined the retinas of Rpe65-deficient dogs after RPE65 gene therapy to evaluate the preservation of rods and cone photoreceptor subtypes. We found that gene therapy preserves both rods and cones. While the moderate loss of rods in the Rpe65-deficient dog retina is slowed by gene therapy, S-cones are lost extensively and gene therapy can prevent that loss, although only within the treated area. Although LM-cones are not lost extensively, cone opsin mislocalization indicates that they are stressed, and this can be partially reversed by gene therapy. Our results suggest that gene therapy may be able to slow cone degeneration in patients if intervention is sufficiently early and also that it is probably important to treat the macula in order to preserve central function.
Asunto(s)
Amaurosis Congénita de Leber/terapia , Células Fotorreceptoras Retinianas Conos , Células Fotorreceptoras Retinianas Bastones , cis-trans-Isomerasas/genética , Animales , Supervivencia Celular/genética , Modelos Animales de Enfermedad , Perros , Terapia Genética , Amaurosis Congénita de Leber/genética , Amaurosis Congénita de Leber/patología , Retina/efectos de los fármacos , Retina/patología , Células Fotorreceptoras Retinianas Conos/efectos de los fármacos , Células Fotorreceptoras Retinianas Conos/patología , Células Fotorreceptoras Retinianas Bastones/efectos de los fármacos , Células Fotorreceptoras Retinianas Bastones/patología , cis-trans-Isomerasas/administración & dosificación , cis-trans-Isomerasas/deficienciaRESUMEN
Noninfectious intraocular inflammatory disease remains a significant cause of visual loss, even with current systemic immunosuppression. Alternative novel treatments are thus required, particularly for severe forms of posterior uveitis. Encouraging results from several phase I/II clinical trials of gene therapy for monogenic retinal disorders have paved the way for the development of this approach for other ocular conditions. Gene therapy for uveitis offers the possibility of potent, self-regulating, long-term disease control following a single treatment and without systemic side effects. To date, gene therapy approaches using interleukin-10, interleukin-1 receptor antagonist, interferon-alpha, soluble TNF-alpha receptors, and alpha-MSH gene transfer have been used successfully to attenuate experimental animal models of uveitis. This review evaluates these preclinical studies, considers the route to clinical application, and explores future targets and approaches.
Asunto(s)
Terapia Genética/métodos , Uveítis/terapia , Animales , Humanos , Resultado del TratamientoRESUMEN
Cell transplantation is a potential strategy for treating blindness caused by the loss of photoreceptors. Although transplanted rod-precursor cells are able to migrate into the adult retina and differentiate to acquire the specialized morphological features of mature photoreceptor cells, the fundamental question remains whether transplantation of photoreceptor cells can actually improve vision. Here we provide evidence of functional rod-mediated vision after photoreceptor transplantation in adult Gnat1−/− mice, which lack rod function and are a model of congenital stationary night blindness. We show that transplanted rod precursors form classic triad synaptic connections with second-order bipolar and horizontal cells in the recipient retina. The newly integrated photoreceptor cells are light-responsive with dim-flash kinetics similar to adult wild-type photoreceptors. By using intrinsic imaging under scotopic conditions we demonstrate that visual signals generated by transplanted rods are projected to higher visual areas, including V1. Moreover, these cells are capable of driving optokinetic head tracking and visually guided behaviour in the Gnat1−/− mouse under scotopic conditions. Together, these results demonstrate the feasibility of photoreceptor transplantation as a therapeutic strategy for restoring vision after retinal degeneration.
Asunto(s)
Células Fotorreceptoras Retinianas Bastones/fisiología , Células Fotorreceptoras Retinianas Bastones/trasplante , Visión Ocular/fisiología , Animales , Subunidades alfa de la Proteína de Unión al GTP/deficiencia , Subunidades alfa de la Proteína de Unión al GTP/genética , Luz , Aprendizaje por Laberinto , Ratones , Células Bipolares de la Retina/ultraestructura , Células Horizontales de la Retina/ultraestructura , Células Fotorreceptoras Retinianas Bastones/citología , Células Fotorreceptoras Retinianas Bastones/efectos de la radiación , Transducina/deficiencia , Transducina/genética , Visión Ocular/efectos de la radiación , Corteza Visual/fisiología , Corteza Visual/efectos de la radiaciónRESUMEN
Degeneration of the neural retina is the leading cause of untreatable blindness in the developed world. Stem cell replacement therapy offers a novel strategy for retinal repair. Postmitotic photoreceptor precursors derived from the early postnatal (P) retina are able to migrate and integrate into the adult mouse retina following transplantation into the subretinal space, but it is likely that a large number of these cells would be required to restore vision. The adult recipient retina presents a very different environment to that from which photoreceptor precursor donor cells isolated from the developing postnatal retina are derived. Here we considered the possibility that modulation of the recipient environment by ectopic expression of developmentally regulated growth factors, normally present during photoreceptor development, might enhance the migration and integration of transplanted cells into the adult neural retina. Adeno-associated viral (AAV) vectors were used to introduce three growth factors previously reported to play a role in photoreceptor development, IGF1, FGF2, and CNTF, into the adult retina, prior to transplantation of P4 cells derived from the Nrl.GFP(+ve) neural retina. At 3 weeks posttransplantation the number of integrated, differentiated photoreceptor cells present in AAV-mediated neurotrophic factor-treated eyes was assessed and compared to control treated contralateral eyes. We show, firstly, that it is possible to manipulate the recipient retinal microenvironment via rAAV-mediated gene transfer with respect to these developmentally relevant growth factors. Moreover, when combined with cell transplantation, AAV-mediated expression of IGF1 led to significantly increased levels of cell integration, while overexpression of FGF2 had no significant effect on integrated cell number. Conversely, expression of CNTF led to a significant decrease in cell integration and an exacerbated glial response that led to glial scarring. Together, these findings demonstrate the importance of the extrinsic environment of the recipient retina for photoreceptor cell transplantation and show for the first time that it is possible to manipulate this environment using viral vectors to influence photoreceptor transplantation efficiency.
Asunto(s)
Células Fotorreceptoras de Vertebrados/citología , Retina/citología , Animales , Diferenciación Celular , Supervivencia Celular , Factor Neurotrófico Ciliar/genética , Factor Neurotrófico Ciliar/metabolismo , Dependovirus/genética , Factor 2 de Crecimiento de Fibroblastos/genética , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Terapia Genética , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , Ratones , Ratones Endogámicos C57BL , Células Fotorreceptoras de Vertebrados/trasplante , Retina/patología , Retina/ultraestructura , Degeneración Retiniana/patología , Degeneración Retiniana/terapiaRESUMEN
Transfer of cDNA to corneal endothelial cells has been demonstrated in cell monolayers in vitro, in endothelium of whole thickness corneas ex vivo and following intracameral injection. Studies examining the feasibility and optimal methods for gene transfer to the cornea have used viral and non-viral vectors, initially histochemical or fluorescent marker genes, and in endothelium of numerous species ranging from mouse to man. As the feasibility of genetic modification of corneal endothelial cells has been successfully demonstrated in a number of cell culture and animal models, there is significant potential for gene transfer in the treatment of human corneal endothelial disease. The two most widely studied applications of gene transfer to endothelium are (i) transduction of immunomodulatory genes to donor corneal endothelium prior to transplantation as a strategy to delay allogeneic rejection and (ii) modulation of apoptosis or induction of replication in human corneal endothelial cells to increase cell density. Although continued improvements in vectors for gene transfer will improve the efficacy and safety of gene therapy, more detailed understanding of the altered biology of endothelium in disease will be necessary to allow selection of appropriate targets for a gene-based treatment approach.
Asunto(s)
Córnea/irrigación sanguínea , Enfermedades de la Córnea/terapia , Células Endoteliales/metabolismo , Técnicas de Transferencia de Gen , Terapia Genética/métodos , Animales , Enfermedades de la Córnea/genética , Enfermedades de la Córnea/metabolismo , Enfermedades de la Córnea/patología , Trasplante de Córnea/efectos adversos , Células Endoteliales/patología , Vectores Genéticos , Rechazo de Injerto/genética , Rechazo de Injerto/prevención & control , HumanosRESUMEN
Over the last decade, gene supplementation therapy for inherited retinal degeneration has come of age. Early proof-of-concept studies in animal models of disease showed modest, but genuine improvements in retinal function and/or survival. Further development of the vectors used for gene transfer to the retina has led to better treatment efficacy in a wide variety of animal models, leading in 2008 to the initiation of three clinical trials for Leber congenital amaurosis caused by retinal pigment epithelium 65 deficiency. The results from these trials suggest that the treatment of inherited retinal dystrophy by gene therapy can be safe and effective. Here, we examine the progress of gene supplementation therapy in the retina, and discuss the potential for using gene therapy to treat different forms of inherited retinal degeneration.
Asunto(s)
Terapia Genética , Amaurosis Congénita de Leber/terapia , Retina/patología , Distrofias Retinianas/genética , Distrofias Retinianas/terapia , Animales , Ensayos Clínicos como Asunto , Modelos Animales de Enfermedad , Proteínas del Ojo/genética , Proteínas del Ojo/metabolismo , Genes Recesivos , Humanos , Amaurosis Congénita de Leber/genética , Células Fotorreceptoras/metabolismo , Células Fotorreceptoras/patologíaRESUMEN
Substantial advances in our understanding of lentivirus lifecycles and their various constituent proteins have permitted the bioengineering of lentiviral vectors now considered safe enough for clinical trials for both lethal and non-lethal diseases. They possess distinct properties that make them particularly suitable for gene delivery in ophthalmic diseases, including high expression, consistent targeting of various post-mitotic ocular cells in vivo and a paucity of associated intraocular inflammation, all contributing to their ability to mediate efficient and stable intraocular gene transfer. In this review, the intraocular tropisms and therapeutic applications of both primate and non-primate lentiviral vectors, and how the unique features of the eye influence these, are discussed. The feasibility of therapeutic targeting using these vectors in animal models of both anterior and posterior ophthalmic disorders has been established, and has, in combination with substantial progress in enhancing lentiviral vector bio-safety over the past two decades, paved the way for the first human ophthalmic clinical trials using lentivirus-based gene transfer vectors.